[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-366236-105":59,"doc-detail-366236-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrative-analysis-of-ras-signaling-effectors-reveals-stage-dependent-oncogenic-patterns-in-colon-adenocarcinoma","Integrative analysis of RAS signaling effectors reveals stage-dependent oncogenic patterns in colon adenocarcinoma","","Cancer rarely arises from a single gene defect; it emerges from disruptions in complex cellular networks. Using a Network Medicine perspective, the study investigates cancer-driving interactions within RAS signaling pathways, analyzing gene expression in colon and lung cancers. Computational modeling combined with patient tissue analysis identifies five key early-stage colon cancer genes—RAF1, PLCE1, RGL1, RIN1, and GRB7—as RAS effectors. These genes distinguish normal from cancerous colon tissue and suggest targeting early RAS-related alterations for earlier therapeutic intervention.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrative-analysis-of-ras-signaling-effectors-reveals-stage-dependent-oncogenic-patterns-in-colon-adenocarcinoma/366236/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrative-analysis-of-ras-signaling-effectors-reveals-stage-dependent-oncogenic-patterns-in-colon-adenocarcinoma/366236.png","ImageObject",300,407,{"name":92,"@type":93},"Terk","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-10-23","2026-09-23",true,{"@type":102,"interactionType":103,"userInteractionCount":29},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What research framework guides the study of cancer-driving interactions?","Question",{"text":112,"@type":113},"The study uses the Network Medicine perspective, focusing on the RAS interactome and its signaling pathways rather than RAS alone.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How were stage-specific molecular drivers identified?",{"text":117,"@type":113},"The researchers analyzed gene expression patterns in colon and lung cancers, combining computational modeling with patient tissue analysis to find stage-specific drivers.",{"name":119,"@type":110,"acceptedAnswer":120},"Which genes were found to be altered specifically in early-stage colon cancer?",{"text":121,"@type":113},"Five key genes were identified as specifically altered in early-stage colon cancer: RAF1, PLCE1, RGL1, RIN1, and GRB7.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},366236,1791229794,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":29,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099525198933,"https://ap-avatar.wpscdn.com/davatar_155a257f0dc6eb9ab79c44ca47cae57d","Biotechnology Reports 47 (2025) e00902  \nContents lists available at ScienceDirect  \nBiotechnology Reports  \njournal [homepage:](homepage: www.elsevier.com/locate/btre)[ www.elsevier.com/locate/btre](homepage: www.elsevier.com/locate/btre)  \n| Research Article\u003Cbr>Integrative analysis of RAS signaling effectors reveals stage-dependent oncogenic patterns in colon adenocarcinoma\u003Cbr>Loretta L´aszl´o a,b, Anna Lovrics a,*, ´Almos Tilajkaa,b, Tam´as Tak´acs a,b, L´aszl´o Buday a,c, Virag Vasa,* \u003Cbr>a Institute of Molecular Life Sciences, HUN-REN Research Centre for Natural Sciences, Budapest, 1117, Hungary b Doctoral School of Biology, Institute of Biology, ELTE E¨otv¨os Lor´and University, Budapest, 1117, Hungary c Department of Molecular Biology, Semmelweis University, Budapest, 1094, Hungary |  |  |\n| --- | --- | --- |\n| A R T I C L E I N F O |  | A B S T R A C T |\n| Keywords: Interactome analysis RAS effectors COAD\u003Cbr>PLCE1\u003Cbr>RAF1\u003Cbr>GRB7\u003Cbr>RIN1\u003Cbr>RGL1 |  | Cancer rarely results from a single gene defect but emerges from disruptions in complex cellular networks. The Network Medicine perspective guides our investigation of cancer-driving interactions, particularly focusing on RAS signaling pathways that are key mediator for cancer development.\u003Cbr>We analyzed gene expression patterns in colon and lung cancers to identify stage-specific molecular drivers. Using computational modelling combined with patient tissue analysis, we discovered five key genes that are specifically altered in early-stage colon cancer: RAF1, PLCE1, RGL1, RIN1, and GRB7. These genes work as RAS effectors in signaling and can effectively distinguish between normal and cancerous colon tissue.\u003Cbr>Our approach combines network analysis with gene expression studies to understand how RAS signaling disruption contributes to colon cancer development. These findings suggest that targeting early-stage RASrelated changes could offer therapeutic opportunities before cancer becomes more complex and harder to treat. |\n\nAbbreviations  \nCOAD colon adenocarcinoma LUAD lung adenocarcinoma  \nLUSC lung squamous cell carcinoma PLCE1 Phospholipase C epsilon 1  \nRAF1 Rapidly Accelerated Fibrosarcoma Serine/Threonine Kinase 1 (other name CRAF)  \nGRB7 Growth Factor Receptor-Bound Protein 7  \nRIN1 Ras and Rab interactor 1  \nRGL1 Ral Guanine Nucleotide Dissociation Stimulator Like 1  \n1. Introduction  \nOver the past 60 years, research has advanced our understanding of RAS proteins (KRAS, NRAS, HRAS) as oncogenes, elucidating their crystal structure, mutations and RAS GDP-GTP exchange regulation by guanine nucleotide exchange factors (GEFs) and GTPase-activating proteins (GAPs) (for a review, see [1]). Despite progress, RAS remains difficult to target therapeutically, though promising inhibitors have  \nemerged for certain lung cancers [2–4].  \nSince cancer results from complex molecular disruptions rather than single gene defects, the Network Medicine framework pioneered by A. L. Barab´asi [5], focusing on the RAS interactome instead of RAS itself offers a valuable perspective. The Network Medicine concept, is especially useful for comprehending the molecular complexity of cancer and for identifying diagnostic or prognostic biomarkers [6–8]. In contrast to traditional strategies, which frequently focus on alterations in a single gene or protein, such as the RAS oncogene, Network Medicine allows conducting a thorough examination of large signaling cascade modules as the RAS interacting effectors. This approach enables us to explore not only RAS’s standalone role, but also its dynamic interactions in cellular signaling networks.  \nThe starting point of this study was that the hub-position of RAS interactome in cellular signalling as well as their varied functions that substantial impact the plasticity of signal transduction might be a potential target to this end. When RAS-driven effects are accelerated either via activating RAS mutations, changes in RAS expression levels in cancer cel","cbCailBL4CiIHCJl","https://ap.wps.com/l/cbCailBL4CiIHCJl","pdf",9260836,18,"English","# Abstract\n# Abbreviations\n## 1. Introduction","[{\"question\":\"What research framework guides the study of cancer-driving interactions?\",\"answer\":\"The study uses the Network Medicine perspective, focusing on the RAS interactome and its signaling pathways rather than RAS alone.\"},{\"question\":\"How were stage-specific molecular drivers identified?\",\"answer\":\"The researchers analyzed gene expression patterns in colon and lung cancers, combining computational modeling with patient tissue analysis to find stage-specific drivers.\"},{\"question\":\"Which genes were found to be altered specifically in early-stage colon cancer?\",\"answer\":\"Five key genes were identified as specifically altered in early-stage colon cancer: RAF1, PLCE1, RGL1, RIN1, and GRB7.\"}]","Integrative analysis of RAS signaling effectors reveals stage-dependent oncogenic patterns in colon adenocarcinoma | PDF",1790164334,45,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/33a05b559d5da54da8725c2691027024.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/5b10193167f656ade91990c38dfcfa02.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3e4ee76565fe5ec10860b8647356fa8b.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/780f2432f1b19af6a0f60633ee5302f4.webp",980,1306]